About G-MEDS
G-MEDS was founded in 2015 in Singapore and operates in the health technology sector. An e-pharmacy platform is offered to assist doctors in managing prescriptions for traveling patients. Auto-refill reminders are included to minimize gaps in medication supply, particularly for those with chronic conditions. Electronic records of patient histories are maintained for straightforward review and access to essential information.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Gmedes Pte Ltd
-
Annual Revenue
$823.62 K (USD)6523as on Dec 31, 2020
-
Net Profit
-$650.07 K (USD)32as on Dec 31, 2020
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of G-MEDS
Investors in G-MEDS
G-MEDS has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include 500 Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and acceleration are provided to tech startups.
|
Locked | Locked | Locked |
Investor details for G-MEDS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by G-MEDS
Investment portfolio details for G-MEDS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - G-MEDS
Detailed financials for G-MEDS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
G-Meds Comparisons
Peer comparison for G-MEDS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of G-MEDS
Detailed competitors of G-MEDS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on G-Meds
Complete news archive for G-MEDS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about G-MEDS
G-MEDS was founded in 2015 and raised its 1st funding round 4 years after it was founded.
G-MEDS is headquartered in Singapore, Singapore.
Annual revenue of G-MEDS is $823.62K as on Dec 31, 2020.
G-MEDS was founded in 2015 in Singapore and operates in the health technology sector. An e-pharmacy platform is offered to assist doctors in managing prescriptions for traveling patients. Auto-refill reminders are included to minimize gaps in medication supply, particularly for those with chronic conditions. Electronic records of patient histories are maintained for straightforward review and access to essential information.
G-MEDS has 1 investor. Key investors include 500 Global.